Vendor, Rockville, MD
Dna Hive LLC
UEI ZULRXE8XYEM3, CAGE 8B9Q6
1 award and $3,090,715 obligated between September 23, 2025 and September 23, 2025, 100% under full and open competition, against 1.0 offers on average where reported. 10 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $3,090,715 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Hive 2.0: Expansion of FDA ARGOS
Food and Drug Administration, FDA Office of Acq Grant SVCS
PresolicitationNAICS 541714Maryland75F40125C00095Awarded to Dna Hive LLC
Posted Jun 17
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40125C00095Definitive Contract, September 23, 2025, Full and Open Competition, 1 offersSolicitation | FDA Office of Acq Grant SVCSFood and Drug Administration | Baa# Fy25c3ap3 - (H20) a Next Generation Medical Countermeasures Scientific Platform for Regulatory Evaluation and PreparednessNAICS 541714, PSC AN11 | $3,090,715 |
- Places of performance
- Maryland
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 1 across 1 awards